Emergency ambulatory outpatient management of immune-mediated hypophysitis
AffiliationDepartment of Acute Medicine and Critical Care, The Christie, Wilmslow Road, Manchester, UK
MetadataShow full item record
AbstractPurpose: Immune-mediated hypophysitis is an important toxicity related to immune checkpoint inhibitors (ICI). Optimal management is associated with improved outcomes. It represents a wide spectrum of clinical presentations, and a proportion may be suitable for emergency ambulatory management. Methods: Emergency ambulatory management of patients presenting with clinical features and findings consistent with ICI-induced hypophysitis was considered at a tertiary cancer/endocrinology hospital. Suitable patients were initially investigated and treated in accordance with the UK emergency management guidelines for ICI induced hypophysitis. After an initial observation period of 4 h, patients were discharged with oral hydrocortisone (20, 10, 10 mg). Results: An initial cohort of 4 patients with emergency presentations of ICI-induced hypophysitis has been managed in an ambulatory fashion in the first 3 months. There were no 30-day readmissions. Conclusion: Carefully selected emergency presentations with immune-mediated hypophysitis may be suitable for ambulatory management. Keywords: Ambulatory; Emergency oncology; Hypophysitis; Immune checkpoint inhibitors.
CitationCooksley T, Knight T, Gupta A, Higham C, Lorigan P, Adam S. Emergency ambulatory outpatient management of immune-mediated hypophysitis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2020;28(9):3995-9.
JournalSupportive Care in Cancer
- Immune checkpoint inhibitor-mediated hypophysitis: no place like home.
- Authors: Cooksley T, Knight T, Lindsay D, Gupta A, Ho JH, Higham C, Lorigan P, Adam S
- Issue date: 2023 Jan
- Hypophysitis from immune checkpoint inhibitors: challenges in diagnosis and management.
- Authors: Kotwal A
- Issue date: 2021 Aug 1
- Emergency Presentations of Immune Checkpoint Inhibitor-Related Endocrinopathies.
- Authors: Knight T, Cooksley T
- Issue date: 2021 Aug
- MANAGEMENT OF ENDOCRINE DISEASE: Immune check point inhibitors-induced hypophysitis.
- Authors: Albarel F, Castinetti F, Brue T
- Issue date: 2019 Sep 1
- Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors´ treatment: Spectrum of imaging appearances.
- Authors: Malikova H, Holesta M, Fialova A, Arenbergerova M, Weichet J
- Issue date: 2018 Sep